13Sep 2023
Impact of prior use of topical hemostatic agents on trial of labor after cesarean

Impact of prior use of topical hemostatic agents on trial of labor after cesarean

A recent study finds no significant link between using a topical hemostatic agent during cesarean delivery and uterine scar disruption during a subsequent trial of labor after cesarean (TOLAC). The multicenter retrospective cohort study, spanning from 2005 to 2021, analyzed 7199 women who underwent TOLAC, with 6.0% having previously used a hemostatic agent during cesarean delivery. Univariate and multivariate analyses showed no significant associations between hemostatic agent use and uterine scar rupture, dehiscence, or TOLAC failure. This study suggests that a history of hemostatic agent use does not increase the risk of uterine scar disruption during subsequent TOLAC.

  • #gynaecology - ivf

Like

Save

Share